drugset / Trial / NCT00238862

Treatment of PED With AMT and Autologous Serum

NCT00238862

Completed 180 enrolled King Khaled Eye Specialist Hospital
RandomizedSingle-groupOpen-labelTreatment

Summary

Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%. Outcome measures will be (1) presence or absence of complete re-epithelialization within 28 days and (2) retention of intact epithelium for at least 90 days.

Timeline

Start
2005-10
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous serum Unknown 20 %

Indications